Breaking News

New R&D Director at DS Healthcare

May 21, 2014

Patel to develop hair care, skin care and more.

DS Healthcare Group, Inc. (DSKX) appointed Dr. Brijeshkumar Patel, PhD to the newly created position of director of research and development. In this role Dr. Patel will focus on the development of transdermal drug delivery systems for the Company's hair-care products, as well as restructuring existing and new molecules for increased absorption and effectiveness. He will work alongside a team of chemists both within DS Healthcare and with the company's external consultants to develop skin-care applications.
 
In addition to maintaining the highest quality controls for the company's over-the-counter formulations, Dr. Patel will also collaborate with Aptiv Solutions, DS Healthcare's clinical research organization (CRO) on the company's prescription-grade hair formulation currently under development.
 
"We are executing on the pursuit of science that enhances hair regrowth and youthful skin. Dr. Patel joins us as Director of R&D to lead our clinical development efforts for both our prescription hair loss development program and our portfolio of over-the-counter hair care and skin care products," stated DS Healthcare President and CEO Daniel Khesin. "We've seen demand for our over-the-counter products continue to grow based on the performance of our proprietary, patent-pending formulations. With Dr. Patel on our team, we believe we will be in a position to accelerate our innovation and clinical programs with a goal towards expanding our intellectual property, product portfolio and corresponding revenues."
 
Dr. Patel has over seven years of research experience in developing novel drug delivery systems for pulmonary, oral and topical delivery of small molecules and peptide drugs. He brings to DS Healthcare specific expertise in designing preclinical and clinical study protocols. He has authored 10 articles published in peer-reviewed scientific publications and delivered over a dozen poster and oral presentations at scientific conferences.
 
In other news, DS Healthcare Group recently announced its intention to file an Investigational New Drug application with the U.S. Food and Drug Administration for a topical hair loss treatment. If approved, it would be the third FDA-approved treatment for hair loss and only the second topical treatment. The company has recently filed two patents for its prescription and over-the-counter hair loss formulations.
 
  • Fit for Fitness

    Fit for Fitness

    Christine Esposito, Associate Editor||February 21, 2017
    Kinx Active is a new brand targeting women who want beauty products that can stand up to their fitness routines.

  • Cargo Says Aloha To Spring/Summer

    Cargo Says Aloha To Spring/Summer

    Christine Esposito, Associate Editor||February 13, 2017
    Cargo Cosmetics has rolled out its new Spring/Summer collection with Hawiianan singer Anuhea.

  • Cashing In on Coconuts

    Cashing In on Coconuts

    Melissa Meisel, Associate Editor||February 6, 2017
    Organic to Green is making waves for its new oils and eco-friendly packaging.

  • Trade Association Directory 2017

    February 2, 2017
    Contact details of trade associations that serve various segments of our industry and are mentioned frequently in Happi.

  • What the Halal  Is Going On?

    What the Halal Is Going On?

    Imogen Matthews , In-Cosmetics||February 2, 2017
    Demand for these beauty products is surging thanks to a fastgrowing Muslim population.

  • Relief for Sensitive Scalps

    Relief for Sensitive Scalps

    Guadalupe Pellon and Annette Mehling , BASF||February 2, 2017
    BASF researchers detail the attributes of the company’s highly effective hair care system focusing on scalp sensitivity.